Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat

por Mathiesen, David S., Lund, Asger, Vilsbøll, Tina, Knop, Filip K., Bagger, Jonatan I.
Publicado 2021

Unprecedented high insulin secretion in a healthy human subject after intravenous glucagon-like peptide-1: a case report

por Knop, Filip K, Lund, Asger, Madsbad, Sten, Holst, Jens J, Krarup, Thure, Vilsbøll, Tina
Publicado 2014

On the role of gallbladder emptying and incretin hormones for nutrient-mediated TSH suppression in patients with type 2 diabetes

por Sonne, David P, Lund, Asger, Faber, Jens, Holst, Jens J, Vilsbøll, Tina, Knop, Filip K
Publicado 2014

Protocol for Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetes Cases (The MAG1C trial): a randomised, double-blinded, placebo-controlled trial

por Johansen, Nicklas Järvelä, Dejgaard, Thomas Fremming, Lund, Asger, Vilsbøll, Tina, Andersen, Henrik Ullits, Knop, Filip Krag
Publicado 2018

Glucose-Dependent Insulinotropic Polypeptide (GIP) Reduces Bone Resorption in Patients With Type 2 Diabetes

por Christensen, Mikkel B, Lund, Asger B, Jørgensen, Niklas R, Holst, Jens J, Vilsbøll, Tina, Knop, Filip K
Publicado 2020

The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion—A Review

por Mathiesen, David S., Bagger, Jonatan I., Bergmann, Natasha C., Lund, Asger, Christensen, Mikkel B., Vilsbøll, Tina, Knop, Filip K.
Publicado 2019

Response to Letter to the Editor from McKee and McGill: “Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring”...

por Juel, Caroline T B, Dejgaard, Thomas F, Hansen, Carsten P, Storkholm, Jan H, Vilsbøll, Tina, Lund, Asger, Knop, Filip K
Publicado 2021

The Role of Glucagon in the Acute Therapeutic Effects of SGLT2 Inhibition

por Hædersdal, Sofie, Lund, Asger, Nielsen-Hannerup, Elisabeth, Maagensen, Henrik, van Hall, Gerrit, Holst, Jens J., Knop, Filip K., Vilsbøll, Tina
Publicado 2020

Hepatic microbiome in healthy lean and obese humans

por Suppli, Malte Palm, Bagger, Jonatan Ising, Lelouvier, Benjamin, Broha, Amandine, Demant, Mia, Kønig, Merete Juhl, Strandberg, Charlotte, Lund, Asger, Vilsbøll, Tina, Knop, Filip Krag
Publicado 2021

No detectable effect of a type 2 diabetes-associated TCF7L2 genotype on the incretin effect

por Mathiesen, David S, Bagger, Jonatan I, Hansen, Katrine B, Junker, Anders E, Plamboeck, Astrid, Harring, Signe, Idorn, Thomas, Hornum, Mads, Holst, Jens J, Jonsson, Anna E, Hansen, Torben, Vilsbøll, Tina, Lund, Asger, Knop, Filip K
Publicado 2020

Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-spectrometry Based Profiling of Human Plasma

por Wewer Albrechtsen, Nicolai J., Hornburg, Daniel, Albrechtsen, Reidar, Svendsen, Berit, Toräng, Signe, Jepsen, Sara L., Kuhre, Rune E., Hansen, Marie, Janus, Charlotte, Floyd, Andrea, Lund, Asger, Vilsbøll, Tina, Knop, Filip K., Vestergaard, Henrik, Deacon, Carolyn F., Meissner, Felix, Mann, Matthias, Holst, Jens J., Hartmann, Bolette
Publicado 2016

Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production

por Wewer Albrechtsen, Nicolai J., Kuhre, Rune E., Hornburg, Daniel, Jensen, Christian Z., Hornum, Mads, Dirksen, Carsten, Svane, Maria, Gasbjerg, Lærke S., Jørgensen, Nils B., Gabe, Maria N., Balk-Møller, Emilie, Albrechtsen, Reidar, Winther-Sørensen, Marie, Galsgaard, Katrine D., Meissner, Felix, Jorsal, Tina, Lund, Asger, Vilsbøll, Tina, Eliasen, Rasmus, Bojsen-Møller, Kirstine N., Idorn, Thomas, Deacon, Carolyn F., Knop, Filip K., Rosenkilde, Mette M., Hartmann, Bolette, Feldt-Rasmussen, Bo, Mann, Matthias, Madsbad, Sten, Holst, Jens J.
Publicado 2017